LIDE Biotech Showcases Lab Ops Quality with Participation in VERIF.i ® , Scientist.com’s Supplier Pre-assessment Program
Scientist.com, the pharmaceutical industry’s leading R&D marketplace, announced today that LIDE Biotech has successfully completed VERIF.i® on-site assessments at two of its China-based facilities—Shanghai and Xi’an. VERIF.i is Scientist.com’s on-site pre-assessment program that helps suppliers of regulated services demonstrate the quality and standards of their laboratories to both existing and prospective clients.
LIDE is an award-winning, translational medicine contract research organization (CRO) with over a decade of experience delivering preclinical drug evaluation services globally. In addition to offering innovations in oncology translational research and immune-oncology, LIDE has a collection of over 2,000 patient derived xenograft (PDX) models covering 50+ cancer types, of which 200+ are special drug resistant and/or genetically altered. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class, state of the art equipment.
“We’ve adopted the highest global operational standards at LIDE, ensuring our facilities and processes not only meet but surpass industry expectations,” stated Dr. Danyi Wen, President and CEO of LIDE Biotech. “VERIF.i is one more way to demonstrate our commitment to quality and compliance to our biotech and pharmaceutical clients globally.”
VERIF.i provides LIDE Biotech and other suppliers of regulated research services, including human biospecimen acquisition, animal studies and chemistry, manufacturing and controls (CMC) services, the opportunity to proactively communicate the quality and capabilities of their laboratories against pre-defined criteria developed specifically for the biopharma industry. Independent, third-party auditors carry out on-site inspections, the results of which can be shared with clients or used to improve lab operations.
“On-site assessments of laboratories have always been difficult to complete due to high costs and intensive resource and time requirements,” stated Matt McLoughlin, SVP of Categories and Compliance at Scientist.com. “VERIF.i provides a new and viable solution for marketplace sellers and buyers alike. It enables a high-quality supplier like LIDE to differentiate itself from its peers by sharing information about its facilities, personnel and processes. At the same time, it eliminates redundant work and ultimately saves both buyers and sellers time and money."
VERIF.i is an expansion of Scientist.com’s award-winning COMPLi® solution. For more information visit https://www.scientist.com/verifi/
About LIDE Biotech
LIDE biotech is committed to accelerating translation from pre-clinical to clinical for our clients. Our robust database of over 2000+ PDX, CDX, and cell line models is an industry-leading resource. Additionally, LIDE provides proprietary kits (small sample K-cell collection, conditional cell reprogramming, MiniPDX and IO-FIVE assays) that help clients streamline their studies. Most importantly, our hospital collaborations offer clients an unparalleled translational platform to leverage in their drug R&D journey. Our CRO services can be custom tailored or leveraged with out-of-the-box solutions, including in vitro and in vivo studies, 3D and organoid approaches, all supplemented with in-house bioinformatics and a parallel immuno-oncology platform.
Visit www.lidebiotech.com to learn more and follow updates on the LIDE Biotech LinkedIn page.
About Scientist.com
Scientist.com is a privately held San Diego-based company on a mission to make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace that helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Through Scientist.com, scientists communicate directly with research experts at over 5,000 global laboratories to design and execute complex research experiments. Visit scientist.com to learn more.
Join Scientist.com on social media: LinkedIn, Twitter, YouTube, Facebook and Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618429370/en/
Contacts
Sean Preci
+1 877-644-044
marketing@scientist.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The Estée Lauder Companies’ New Incubation Ventures and NYKAA Announce the BEAUTY&YOU India 2024 Winners6.11.2024 15:00:00 CET | Press Release
The Estée Lauder Companies’ (NYSE: EL)(“ELC”) New Incubation Ventures (“NIV”) and NYKAA are pleased to announce the winners for BEAUTY&YOU India 2024. Created by NIV and launched in partnership with India’s leading beauty and lifestyle retailer NYKAA, BEAUTY&YOU India continues its mission to discover, spotlight, and propel the next generation of India-focused beauty brands. The 2024 program builds on the success of previous years with the theme of Supercharged Futures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241028661723/en/ (From L to R): Piyush Jain, Dr. Prashant Agrawal, Falguni Nayar, Kritika Rathi, Vijay Sivaraju, Vaishnavi Maganti, Shana Randhava, Stéphane de La Faverie, William P. Lauder, Akshay Bawa, Alia Allana, Sumit Bhasin, Rosemin M. Opgenhaffen (Photo: Business Wire) This year’s program saw more than 660 applicants from over 50 cities in the categories of skin care, makeup, hair care, fragrance, and stor
Biosynth Names Matt Gunnison as CEO, Kieran Murphy Appointed as Chairman6.11.2024 10:30:00 CET | Press Release
Biosynth, a global supplier of critical raw materials and services to the life sciences industry, today announced that its Board of Directors has appointed Matt Gunnison as the company's new Chief Executive Officer and a member of the Board of Directors, effective immediately. The Board has also appointed Kieran Murphy as Chairman, effective as of the same date. Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growth and strengthened its position in the life sciences sector. Urs Spitz will remain a member of the Board of Directors. “We are grateful to Urs for his significant contributions in shaping Biosynth into the innovative and thriving company it is today. We are now excited to welcome Matt as CEO, whose vision and extensive experience will be pivotal in leading the company through its next chapter,” said Kugan Sathiyanandarajah, Partner at KKR and Head of Europe for KKR’s Health Care Strategic Growth strategy. “I am thrilled to join Bios
KAYTUS Unveils Cutting-Edge V3 Server Family for Next Open, Green and Scale-Up AI Infrastructure6.11.2024 09:53:00 CET | Press Release
KAYTUS, a leading provider of IT infrastructure, has announced the launch of its V3 server family. This latest lineup supports the powerful Intel® Xeon® 6 processors and AMD EPYC™ 9005 series processors, offering 17 versatile server models designed for general computing, multi-node configurations, critical computing, storage optimization, and rack-scale systems. The V3 server family is engineered with enhanced intelligence and groundbreaking cooling solutions, ensuring seamless support for diverse AI applications. Packed with advanced computing and storage technologies, it maximizes CPU bus bandwidth, memory bandwidth, and overall capacity. The dual-socket models boast up to 576 cores and clock speeds reaching 5.0 GHz, along with an impressive 136% boost in memory bandwidth. Performance tests reveal that in large-model AI inference scenarios, such as LLaMA2, the V3 series achieves up to 3x higher overall performance compared to its predecessor. This press release features multimedia. V
Kioxia Is Adopted for NEDO Project to Develop Manufacturing Technology for Innovative Memory Under the Post-5G System Infrastructure Project6.11.2024 09:39:00 CET | Press Release
Kioxia Corporation, a world leader in memory solutions, today announced that it has been adopted by Japan's national research and development agency, New Energy and Industrial Technology Development Organization (NEDO), for its groundbreaking proposal on the Development of Manufacturing Technology for Innovative Memory to enhance the post-5G information and communication system infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241106331046/en/ Memory category by bit density and read time (Graphic: Business Wire) In the post-5G information and communication era, AI is estimated to generate an unprecedented volume of data. This surge will likely escalate the data processing demands of data centers and increase power consumption. To address this, it is crucial that the next-generation memories facilitate rapid data transfer with high-performance processors while increasing capacity and reducing power consumption. A
PayPay and Alipay+ Extend Enhanced E-Wallet Payment Options to Over 3 Million Merchants Across Japan With Expanded Partnership6.11.2024 09:01:00 CET | Press Release
At the Singapore FinTech Festival 2024, PayPay, Japan's top QR payment operator, today announced an expanded partnership with Alipay+, Ant International’s cross-border mobile payment and digitalisation technology solution, broadening its merchant coverage network across Japan. By working with local partners including PayPay, Alipay+ will now connect over 3 million local merchants to the global payment ecosystem, enabling local businesses and payment partners to provide global visitors seamless and secure payment and travel experiences with their preferred domestic e-wallets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241105682881/en/ Travellers can use Alipay+ wallets to scan the PayPay QR code for payment at the vast majority of PayPay stores. (Photo: Business Wire) Through this expanded partnership, travellers using Alipay+ payment partner apps will be able to scan PayPay QR codes to make payments at a wide range of me
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom